番茄果汁衍生的酸脂肪酸:合成和抗血小板活性
Lyanne Rodríguez1, Felipe Lagos1, Mauricio Mastrogiovanni2
1Thrombosis and Healthy Aging Research Center, Department of Clinical Biochemistry and Immunohaematology, Faculty of Health Sciences, University of Talca, Talca 3460000, Chile.
化番茄果汁化合物,包括化脂肪酸 (NO2-FA),表现出强大的抗血小板特性. 这种天然产品为预防血栓和控制心血管疾病提供了一个有希望的策略.
科学领域:
- 心血管研究研究心血管研究
- 食品科学 食品科学 食品科学
- 生物化学 生物化学
背景情况:
- 心血管疾病仍然是全球死亡的主要原因.
- 血小板聚合在血栓事件中起着至关重要的作用.
- 番茄被认为具有潜在的健康益处,包括抗血小板活性.
研究的目的:
- 为了研究番茄果汁的抗血小板特性.
- 确定导致这些影响的特定酸脂肪酸 (NO2-FA).
- 探索NO2-FA在预防心血管疾病方面的治疗潜力.
主要方法:
- 协奏质谱法被用于识别NO2-FA.
- 进行了血小板聚合试验 (基于微型血小板).
- 流细胞计评估了血小板激活标志物.
主要成果:
- 酸脂肪酸,特别是NO2-OA,NO2-LA和NO2-LnA,被确定为关键的抗血小板化合物.
- 化番茄果显示出由TRAP-6和原原诱导的血小板激活的度依赖抑制.
- 与化番茄果汁提取物观察到协同作用的抗血小板作用.
结论:
- 来自番茄果汁的NO2-FA具有显著的抗血小板潜力.
- 酸的番茄果汁提取物在抑制血小板聚合方面比非酸更有效.
- 这项研究支持使用天然产品,如番茄,用于预防和治疗心血管疾病.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
07:13Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
Published on: January 7, 2019
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Antihypertensive Drugs: Vasodilators
